Prostate cancer with small-cell morphology: An immunophenotypic subdivision

Abstract

U-PC-SCM with a neuroendocrine immunophenotype is a histogenetically distinct entity with different clinical and laboratory manifestations which responds well to a cisplatin + etoposide CTH regimen.